Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (2362)	10/16/1997 1:23:00 PM
From: Zirdu	of 6136

Henry, even if you are correct and the PI Failure rate does eventually approach 100% for all patients, given enough time, you have still not answered John W's point: If there is no other viable alternative at this time, and in the forseeable future, then patients will still use the best known therapy to prolong life, which includes Viracept. It will be disappointing to all if the triple therapy is not more successful than your pessimistic scenario. But even in the case of eventual 100% failure rates, the triple cocktailt still will have a lot of value and be the best alternative out there. Yes I know that another miracle therapy for HIV might be found, but so far I haven't seen evidence of it. RR

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next